Tag: #Global Trends

On January 20, 2026, Corvus Pharmaceuticals saw its stock price nearly triple following the release of Phase 1 clinical trial... Read more

In its financial report released January 21, 2026, Johnson & Johnson (J&J) set an ambitious target for the upcoming year,... Read more

Novavax and Pfizer have announced a non-exclusive licensing agreement, marking a pivotal strategic shift for Novavax in 2026. Under the... Read more

During a World Economic Forum event in Davos, Switzerland, Pfizer CEO Albert Bourla offered candid insights into the current healthcare... Read more

Just days after issuing a stern warning to impose new tariffs on eight European nations, President Donald Trump has officially... Read more

A court-appointed special master in New Jersey has recommended that plaintiffs be allowed to present expert witness testimony in the... Read more

Amid the traditional sea of navy and gray at the J.P. Morgan Healthcare Conference in San Francisco, flashes of pink... Read more

AstraZeneca has reached a definitive agreement to acquire the remaining 50% stake in the Chinese development and commercialization rights for... Read more

Johnson & Johnson’s Janssen Biotech unit has signed a multi-target research collaboration with Isomorphic Labs, an Alphabet-backed startup at the... Read more